Does the media refer more to ONC or ELAN?

In the previous week, Elanco Animal Health had 2 more articles in the media than BeOne Medicines. MarketBeat recorded 4 mentions for Elanco Animal Health and 2 mentions for BeOne Medicines. BeOne Medicines' average media sentiment score of 1.53 beat Elanco Animal Health's score of 0.75 indicating that BeOne Medicines is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BeOne Medicines 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Elanco Animal Health 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor ELAN or RPRX?

In the previous week, Royalty Pharma had 2 more articles in the media than Elanco Animal Health. MarketBeat recorded 6 mentions for Royalty Pharma and 4 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 0.75 beat Royalty Pharma's score of 0.63 indicating that Elanco Animal Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elanco Animal Health 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Royalty Pharma 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer ELAN or ZTS?

In the previous week, Zoetis had 2 more articles in the media than Elanco Animal Health. MarketBeat recorded 6 mentions for Zoetis and 4 mentions for Elanco Animal Health. Zoetis' average media sentiment score of 0.89 beat Elanco Animal Health's score of 0.75 indicating that Zoetis is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elanco Animal Health 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Zoetis 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Positive

Does the media refer more to VTRS or ELAN?

In the previous week, Viatris had 2 more articles in the media than Elanco Animal Health. MarketBeat recorded 6 mentions for Viatris and 4 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 0.75 beat Viatris' score of 0.45 indicating that Elanco Animal Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Viatris 0 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Elanco Animal Health 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to ELAN or JAZZ?

In the previous week, Jazz Pharmaceuticals had 10 more articles in the media than Elanco Animal Health. MarketBeat recorded 14 mentions for Jazz Pharmaceuticals and 4 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 0.75 beat Jazz Pharmaceuticals' score of 0.25 indicating that Elanco Animal Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elanco Animal Health 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Jazz Pharmaceuticals 0 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Elanco Animal Health (ELAN) Competitors

$22.45 -0.16 (-0.70%)

Closing price 03:59 PM Eastern

Extended Trading

$22.40 -0.06 (-0.25%)

As of 04:15 PM Eastern

Compare

ELAN vs. ONC, RPRX, ZTS, VTRS, and JAZZ

Should you buy Elanco Animal Health stock or one of its competitors? Elanco Animal Health's main competitors and comparable companies include BeOne Medicines (ONC), Royalty Pharma (RPRX), Zoetis (ZTS), Viatris (VTRS), and Jazz Pharmaceuticals (JAZZ). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Elanco Animal Health compare to BeOne Medicines?

BeOne Medicines (NASDAQ:ONC) and Elanco Animal Health (NYSE:ELAN) are both large-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, media sentiment, risk, profitability, dividends and analyst recommendations.

In the previous week, Elanco Animal Health had 2 more articles in the media than BeOne Medicines. MarketBeat recorded 4 mentions for Elanco Animal Health and 2 mentions for BeOne Medicines. BeOne Medicines' average media sentiment score of 1.53 beat Elanco Animal Health's score of 0.75 indicating that BeOne Medicines is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BeOne Medicines	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Elanco Animal Health	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

BeOne Medicines has higher revenue and earnings than Elanco Animal Health. Elanco Animal Health is trading at a lower price-to-earnings ratio than BeOne Medicines, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BeOne Medicines	$6.13B	6.56	$286.93M	$5.68	64.43
Elanco Animal Health	$5.02B	2.23	-$232M	-$0.41	N/A

BeOne Medicines currently has a consensus target price of $402.71, suggesting a potential upside of 10.05%. Elanco Animal Health has a consensus target price of $29.70, suggesting a potential upside of 32.29%. Given Elanco Animal Health's higher possible upside, analysts clearly believe Elanco Animal Health is more favorable than BeOne Medicines.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BeOne Medicines	0 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	3 Strong Buy rating(s)	3.06
Elanco Animal Health	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75

BeOne Medicines has a beta of 0.51, indicating that its share price is 49% less volatile than the broader market. Comparatively, Elanco Animal Health has a beta of 1.68, indicating that its share price is 68% more volatile than the broader market.

48.5% of BeOne Medicines shares are owned by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are owned by institutional investors. 6.2% of BeOne Medicines shares are owned by insiders. Comparatively, 1.1% of Elanco Animal Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

BeOne Medicines has a net margin of 10.70% compared to Elanco Animal Health's net margin of -3.96%. BeOne Medicines' return on equity of 14.23% beat Elanco Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BeOne Medicines	10.70%	14.23%	7.82%
Elanco Animal Health	-3.96%	8.13%	3.99%

Summary

BeOne Medicines beats Elanco Animal Health on 13 of the 17 factors compared between the two stocks.

How does Elanco Animal Health compare to Royalty Pharma?

Elanco Animal Health (NYSE:ELAN) and Royalty Pharma (NASDAQ:RPRX) are both large-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings, media sentiment and dividends.

Royalty Pharma has a net margin of 32.14% compared to Elanco Animal Health's net margin of -3.96%. Royalty Pharma's return on equity of 30.01% beat Elanco Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elanco Animal Health	-3.96%	8.13%	3.99%
Royalty Pharma	32.14%	30.01%	14.91%

Royalty Pharma has lower revenue, but higher earnings than Elanco Animal Health. Elanco Animal Health is trading at a lower price-to-earnings ratio than Royalty Pharma, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elanco Animal Health	$5.02B	2.23	-$232M	-$0.41	N/A
Royalty Pharma	$2.54B	13.23	$770.95M	$1.45	40.25

Elanco Animal Health has a beta of 1.68, indicating that its stock price is 68% more volatile than the broader market. Comparatively, Royalty Pharma has a beta of 0.44, indicating that its stock price is 56% less volatile than the broader market.

Elanco Animal Health presently has a consensus price target of $29.70, indicating a potential upside of 32.29%. Royalty Pharma has a consensus price target of $61.29, indicating a potential upside of 5.01%. Given Elanco Animal Health's higher possible upside, analysts clearly believe Elanco Animal Health is more favorable than Royalty Pharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elanco Animal Health	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75
Royalty Pharma	0 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, Royalty Pharma had 2 more articles in the media than Elanco Animal Health. MarketBeat recorded 6 mentions for Royalty Pharma and 4 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 0.75 beat Royalty Pharma's score of 0.63 indicating that Elanco Animal Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elanco Animal Health	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Royalty Pharma	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

97.5% of Elanco Animal Health shares are held by institutional investors. Comparatively, 54.3% of Royalty Pharma shares are held by institutional investors. 1.1% of Elanco Animal Health shares are held by company insiders. Comparatively, 18.8% of Royalty Pharma shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Royalty Pharma beats Elanco Animal Health on 10 of the 16 factors compared between the two stocks.

How does Elanco Animal Health compare to Zoetis?

Elanco Animal Health (NYSE:ELAN) and Zoetis (NYSE:ZTS) are both large-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends, media sentiment and earnings.

Elanco Animal Health presently has a consensus price target of $29.70, suggesting a potential upside of 32.29%. Zoetis has a consensus price target of $101.08, suggesting a potential upside of 44.88%. Given Zoetis' higher probable upside, analysts plainly believe Zoetis is more favorable than Elanco Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elanco Animal Health	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75
Zoetis	2 Sell rating(s)	9 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.32

Zoetis has a net margin of 27.49% compared to Elanco Animal Health's net margin of -3.96%. Zoetis' return on equity of 74.89% beat Elanco Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elanco Animal Health	-3.96%	8.13%	3.99%
Zoetis	27.49%	74.89%	18.59%

97.5% of Elanco Animal Health shares are owned by institutional investors. Comparatively, 92.8% of Zoetis shares are owned by institutional investors. 1.1% of Elanco Animal Health shares are owned by insiders. Comparatively, 0.2% of Zoetis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Zoetis has higher revenue and earnings than Elanco Animal Health. Elanco Animal Health is trading at a lower price-to-earnings ratio than Zoetis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elanco Animal Health	$5.02B	2.23	-$232M	-$0.41	N/A
Zoetis	$9.53B	3.03	$2.67B	$6.07	11.49

Elanco Animal Health has a beta of 1.68, suggesting that its stock price is 68% more volatile than the broader market. Comparatively, Zoetis has a beta of 0.73, suggesting that its stock price is 27% less volatile than the broader market.

In the previous week, Zoetis had 2 more articles in the media than Elanco Animal Health. MarketBeat recorded 6 mentions for Zoetis and 4 mentions for Elanco Animal Health. Zoetis' average media sentiment score of 0.89 beat Elanco Animal Health's score of 0.75 indicating that Zoetis is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elanco Animal Health	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Zoetis	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Positive

Summary

Zoetis beats Elanco Animal Health on 11 of the 16 factors compared between the two stocks.

How does Elanco Animal Health compare to Viatris?

Viatris (NASDAQ:VTRS) and Elanco Animal Health (NYSE:ELAN) are both large-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation.

Viatris presently has a consensus target price of $19.50, indicating a potential upside of 10.05%. Elanco Animal Health has a consensus target price of $29.70, indicating a potential upside of 32.29%. Given Elanco Animal Health's stronger consensus rating and higher probable upside, analysts plainly believe Elanco Animal Health is more favorable than Viatris.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Viatris	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.67
Elanco Animal Health	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75

Elanco Animal Health has lower revenue, but higher earnings than Viatris. Elanco Animal Health is trading at a lower price-to-earnings ratio than Viatris, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Viatris	$14.74B	1.38	-$3.51B	-$0.36	N/A
Elanco Animal Health	$5.02B	2.23	-$232M	-$0.41	N/A

79.9% of Viatris shares are owned by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are owned by institutional investors. 0.3% of Viatris shares are owned by insiders. Comparatively, 1.1% of Elanco Animal Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Viatris has a net margin of -2.79% compared to Elanco Animal Health's net margin of -3.96%. Viatris' return on equity of 20.02% beat Elanco Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Viatris	-2.79%	20.02%	8.02%
Elanco Animal Health	-3.96%	8.13%	3.99%

Viatris has a beta of 0.89, meaning that its stock price is 11% less volatile than the broader market. Comparatively, Elanco Animal Health has a beta of 1.68, meaning that its stock price is 68% more volatile than the broader market.

In the previous week, Viatris had 2 more articles in the media than Elanco Animal Health. MarketBeat recorded 6 mentions for Viatris and 4 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 0.75 beat Viatris' score of 0.45 indicating that Elanco Animal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Viatris	0 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Elanco Animal Health	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Elanco Animal Health beats Viatris on 10 of the 17 factors compared between the two stocks.

How does Elanco Animal Health compare to Jazz Pharmaceuticals?

Elanco Animal Health (NYSE:ELAN) and Jazz Pharmaceuticals (NASDAQ:JAZZ) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, media sentiment, risk, earnings and profitability.

In the previous week, Jazz Pharmaceuticals had 10 more articles in the media than Elanco Animal Health. MarketBeat recorded 14 mentions for Jazz Pharmaceuticals and 4 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 0.75 beat Jazz Pharmaceuticals' score of 0.25 indicating that Elanco Animal Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elanco Animal Health	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Jazz Pharmaceuticals	0 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Jazz Pharmaceuticals has a net margin of 20.45% compared to Elanco Animal Health's net margin of -3.96%. Jazz Pharmaceuticals' return on equity of 33.97% beat Elanco Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elanco Animal Health	-3.96%	8.13%	3.99%
Jazz Pharmaceuticals	20.45%	33.97%	13.02%

Elanco Animal Health has higher revenue and earnings than Jazz Pharmaceuticals. Elanco Animal Health is trading at a lower price-to-earnings ratio than Jazz Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elanco Animal Health	$5.02B	2.23	-$232M	-$0.41	N/A
Jazz Pharmaceuticals	$4.60B	3.27	-$356.15M	$14.50	15.97

Elanco Animal Health has a beta of 1.68, indicating that its stock price is 68% more volatile than the broader market. Comparatively, Jazz Pharmaceuticals has a beta of 0.36, indicating that its stock price is 64% less volatile than the broader market.

Elanco Animal Health presently has a consensus price target of $29.70, indicating a potential upside of 32.29%. Jazz Pharmaceuticals has a consensus price target of $291.15, indicating a potential upside of 25.76%. Given Elanco Animal Health's higher possible upside, analysts plainly believe Elanco Animal Health is more favorable than Jazz Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elanco Animal Health	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75
Jazz Pharmaceuticals	0 Sell rating(s)	1 Hold rating(s)	18 Buy rating(s)	1 Strong Buy rating(s)	3.00

97.5% of Elanco Animal Health shares are held by institutional investors. Comparatively, 89.1% of Jazz Pharmaceuticals shares are held by institutional investors. 1.1% of Elanco Animal Health shares are held by company insiders. Comparatively, 4.1% of Jazz Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Jazz Pharmaceuticals beats Elanco Animal Health on 10 of the 16 factors compared between the two stocks.

Get Elanco Animal Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ELAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ELAN vs. The Competition

Export

Metric	Elanco Animal Health	Pharmaceuticals Industry	Healthcare Sector	NYSE Exchange
Market Cap	$11.22B	$12.40B	$7.22B	$22.64B
Dividend Yield	N/A	2.62%	2.52%	3.69%
P/E Ratio	-54.76	792.18	274.02	27.55
Price / Sales	2.23	846.58	664.67	93.29
Price / Cash	9.67	91.32	80.06	41.75
Price / Book	1.70	10.32	10.35	4.60
Net Income	-$232M	$2.83B	$3.50B	$1.08B
7 Day Performance	-0.73%	-1.75%	-1.59%	-1.98%
1 Month Performance	-7.07%	-2.14%	-4.48%	-6.23%
1 Year Performance	11.36%	-0.13%	12.48%	5.08%

Elanco Animal Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ELAN Elanco Animal Health	3.7352 of 5 stars	$22.45 -0.7%	$29.70 +32.3%	+15.1%	$11.22B	$5.02B	N/A	9,900	Analyst Forecast
ONC BeOne Medicines	3.4659 of 5 stars	$365.67 +4.2%	$402.71 +10.1%	+9.7%	$38.52B	$5.34B	64.38	12,000	Gap Up
RPRX Royalty Pharma	4.074 of 5 stars	$58.44 +0.1%	$61.29 +4.9%	+65.2%	$33.59B	$2.38B	40.30	100
ZTS Zoetis	4.8871 of 5 stars	$71.33 -0.1%	$101.08 +41.7%	-50.9%	$29.50B	$9.47B	11.75	14,500
VTRS Viatris	2.3662 of 5 stars	$17.10 +0.9%	$18.71 +9.4%	+88.4%	$19.47B	$14.30B	N/A	30,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ELAN) was last updated on 9/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Elanco Animal Health (ELAN) Competitors

ELAN vs. ONC, RPRX, ZTS, VTRS, and JAZZ

How does Elanco Animal Health compare to BeOne Medicines?

Summary

How does Elanco Animal Health compare to Royalty Pharma?

Summary

How does Elanco Animal Health compare to Zoetis?

Summary

How does Elanco Animal Health compare to Viatris?

Summary

How does Elanco Animal Health compare to Jazz Pharmaceuticals?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELAN vs. The Competition

Elanco Animal Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Elanco Animal Health (ELAN) Competitors

ELAN vs. ONC, RPRX, ZTS, VTRS, and JAZZ

How does Elanco Animal Health compare to BeOne Medicines?

Does the media refer more to ONC or ELAN?

Which has better earnings & valuation, ONC or ELAN?

Do analysts recommend ONC or ELAN?

Which has more volatility and risk, ONC or ELAN?

Do institutionals & insiders have more ownership in ONC or ELAN?

Is ONC or ELAN more profitable?

Summary

How does Elanco Animal Health compare to Royalty Pharma?

Is ELAN or RPRX more profitable?

Which has higher valuation and earnings, ELAN or RPRX?

Which has more risk and volatility, ELAN or RPRX?

Do analysts recommend ELAN or RPRX?

Does the media favor ELAN or RPRX?

Do institutionals and insiders hold more shares of ELAN or RPRX?

Summary

How does Elanco Animal Health compare to Zoetis?

Do analysts prefer ELAN or ZTS?

Is ELAN or ZTS more profitable?

Do institutionals & insiders hold more shares of ELAN or ZTS?

Which has better valuation and earnings, ELAN or ZTS?

Which has more volatility and risk, ELAN or ZTS?

Does the media prefer ELAN or ZTS?

Summary

How does Elanco Animal Health compare to Viatris?

Do analysts rate VTRS or ELAN?

Which has better valuation & earnings, VTRS or ELAN?

Do institutionals and insiders have more ownership in VTRS or ELAN?

Is VTRS or ELAN more profitable?

Which has more risk & volatility, VTRS or ELAN?

Does the media refer more to VTRS or ELAN?

Summary

How does Elanco Animal Health compare to Jazz Pharmaceuticals?

Does the media refer more to ELAN or JAZZ?

Is ELAN or JAZZ more profitable?

Which has preferable valuation and earnings, ELAN or JAZZ?

Which has more volatility and risk, ELAN or JAZZ?

Do analysts rate ELAN or JAZZ?

Do institutionals and insiders have more ownership in ELAN or JAZZ?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELAN vs. The Competition

Elanco Animal Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools